Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia

RP5063 is a multimodal dopamine (D)‐serotonin (5‐HT) stabilizer with a high affinity for D(2/3/4) and 5‐HT(1A/2A/2B/7) receptors and moderate affinity for the serotonin transporter. Single‐dose (10 and 15 mg fasting, 15 mg fed) safety in healthy volunteers and multiple‐dose (10, 20, 50, and 100 mg f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantillon, Marc, Ings, Robert, Bhat, Laxminarayan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039200/
https://www.ncbi.nlm.nih.gov/pubmed/29637739
http://dx.doi.org/10.1111/cts.12545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039200/
https://www.ncbi.nlm.nih.gov/pubmed/29637739
http://dx.doi.org/10.1111/cts.12545

Ejemplares similares